Melasma Treatment Options: Best Approaches for Healthcare Professionals

Melasma: What are the Best Treatments?

Melasma is a common skin condition characterized by brown or grayish-brown patches that usually appear on the face. It affects both men and women but is more prevalent in women, particularly during pregnancy or when taking hormonal medications. This hyperpigmentation disorder can significantly impact an individual's quality of life due to its aesthetic implications. As healthcare professionals, understanding the latest treatment options is vital for effectively managing melasma in patients. In this comprehensive article, we will explore the pathophysiology of melasma, its various causes, and the best available treatments, supported by clinical evidence and current guidelines.

Understanding Melasma

Melasma is a multifactorial skin disorder that primarily affects sun-exposed areas, such as the cheeks, upper lip, forehead, and chin. The exact etiology of melasma is not fully understood; however, several factors, including genetic predisposition, ultraviolet (UV) radiation, hormonal changes, and certain medications, are believed to contribute to its development.

Pathophysiology: Melasma occurs due to increased melanin production by melanocytes, the cells responsible for skin pigmentation. This condition is more common in individuals with darker skin types (Fitzpatrick skin types III–V), who have more active melanocytes. Exposure to UV radiation is a significant trigger, as it stimulates melanogenesis, leading to the characteristic dark patches. Hormonal factors, such as estrogen and progesterone, also play a role, which explains its prevalence in pregnant women and those taking oral contraceptives.

Best Treatments for Melasma

Treatment for melasma can be challenging due to its chronic and recurrent nature. A multifaceted approach that includes sun protection, topical agents, oral medications, chemical peels, laser and light-based therapies, and lifestyle modifications is usually recommended. Here, we will delve into the most effective treatment options supported by scientific research:

1. Sun Protection: The cornerstone of melasma management is rigorous sun protection. UV radiation is a primary exacerbating factor; thus, using broad-spectrum sunscreen with an SPF of at least 30 is crucial. Sunscreens containing physical blockers like zinc oxide and titanium dioxide provide better protection. Additionally, wearing wide-brimmed hats and avoiding sun exposure during peak hours (10 a.m. to 4 p.m.) can help prevent worsening pigmentation.
2. Topical Agents: Topical agents are the first-line treatment for melasma. They work by reducing melanin synthesis, promoting skin turnover, or blocking UV radiation. Some commonly used topical agents include:
   • Hydroquinone: Considered the gold standard in melasma treatment, hydroquinone inhibits tyrosinase, an enzyme essential for melanin production. It is available in concentrations ranging from 2% to 4% and is typically used once or twice daily. However, long-term use may lead to side effects such as ochronosis (a paradoxical hyperpigmentation) and skin irritation. Therefore, hydroquinone should be used under medical supervision.
   • Triple Combination Creams (TCCs): TCCs combine hydroquinone (4%), a corticosteroid (0.01%), and a retinoid (0.05%). This combination enhances the depigmentation effect while reducing the potential side effects of each component. TCCs have demonstrated superior efficacy compared to monotherapy, making them a popular choice for moderate to severe melasma.
   • Retinoids: Topical retinoids like tretinoin (0.025%-0.1%) promote skin cell turnover, helping to disperse melanin granules. They also enhance the penetration of other topical agents like hydroquinone. However, retinoids can cause skin irritation, especially in sensitive skin types, so gradual introduction is advised.
   • Azelaic Acid: Azelaic acid (20%) is a naturally occurring dicarboxylic acid that inhibits tyrosinase activity and has anti-inflammatory properties. It is an effective alternative for patients intolerant to hydroquinone or those seeking a safer long-term option.
   • Tranexamic Acid: Topical tranexamic acid (2%-5%) has gained popularity due to its ability to reduce melanin synthesis by inhibiting the plasminogen/plasmin pathway in the skin. It is well-tolerated and can be combined with other topical agents for enhanced efficacy.
   • Other Agents: Kojic acid, niacinamide, and licorice extract are additional depigmenting agents that can be incorporated into melasma treatment regimens. These agents are generally well-tolerated and can be used alongside other topical treatments.
3. Oral Medications: Certain oral medications have shown promise in the management of melasma, particularly when used in combination with topical therapies.
   • Tranexamic Acid: Oral tranexamic acid (250 mg twice daily) has emerged as an effective treatment for refractory melasma. It works by inhibiting plasmin activity in keratinocytes, reducing melanogenesis. Several studies have reported significant improvement in melasma with oral tranexamic acid, with minimal side effects. However, potential risks like thromboembolism should be considered, especially in patients with a history of clotting disorders.
   • Polypodium Leucotomos Extract (PLE): PLE is a natural antioxidant that provides photoprotection and modulates immune responses in the skin. Oral PLE supplementation has been shown to improve melasma severity when combined with topical agents and sun protection.
   • Glutathione: Glutathione, a powerful antioxidant, has been used as an oral skin-lightening agent. It is thought to inhibit melanin synthesis by converting eumelanin to pheomelanin. While some studies suggest a benefit, more research is needed to establish its efficacy and safety in melasma treatment.
4. Chemical Peels: Chemical peels involve the application of chemical agents that promote controlled exfoliation of the skin, enhancing the penetration of topical agents and reducing pigmentation.
   • Glycolic Acid Peels: Glycolic acid (30%-70%) is an alpha-hydroxy acid (AHA) that accelerates skin cell turnover and exfoliation. It is commonly used in combination with other treatments for mild to moderate melasma. A series of peels is usually required to achieve optimal results.
   • Salicylic Acid Peels: Salicylic acid (20%-30%) is a beta-hydroxy acid (BHA) that penetrates the epidermis and removes excess pigmentation. It is particularly useful for patients with oily or acne-prone skin.
   • TCA (Trichloroacetic Acid) Peels: TCA peels (10%-35%) are medium-depth peels that are effective for deeper melasma. However, they require careful application to prevent complications such as post-inflammatory hyperpigmentation (PIH) and scarring.
5. Laser and Light-Based Therapies: Lasers and light-based devices offer targeted treatment for melasma by destroying melanocytes or breaking down melanin. However, these treatments should be used cautiously, as they carry a risk of PIH, especially in darker skin types.
   • Q-Switched Nd

Laser: The Q-switched Nd

laser (1064 nm) is the most widely used laser for melasma. It targets melanin within the dermis without causing significant damage to surrounding tissues. Multiple sessions are usually required, and the results are often temporary without maintenance therapy.

• Fractional Lasers: Fractional lasers, such as the fractional CO2 and Erbium

​

lasers, create controlled micro-injuries in the skin, promoting collagen remodeling and reducing pigmentation. They are suitable for resistant melasma cases but require a longer downtime and carry a risk of side effects.

1. • Intense Pulsed Light (IPL): IPL devices emit broad-spectrum light that targets melanin and vascular components. While IPL can provide temporary improvement, it is less effective for deeper melasma and may cause PIH.
2. Microneedling: Microneedling, a minimally invasive procedure that creates micro-channels in the skin, can enhance the penetration of topical agents and stimulate collagen production. When combined with tranexamic acid or platelet-rich plasma (PRP), microneedling has shown promising results in melasma management.
3. Lifestyle Modifications and Maintenance: Managing melasma effectively requires a long-term commitment to treatment and lifestyle modifications. Patients should be educated on the importance of sun protection, avoiding potential triggers (e.g., hormonal medications), and adhering to their prescribed treatment regimen. Regular follow-up with a dermatologist is crucial for monitoring progress and adjusting the treatment plan as needed.

Combination Therapy: The Key to Success

Melasma is a chronic condition with a high recurrence rate. Therefore, a combination approach that addresses various pathways of melanin production is often the most effective. For instance, combining topical agents like hydroquinone, retinoids, and sunscreens with chemical peels and oral tranexamic acid can yield better outcomes than monotherapy. Laser treatments can be considered for patients who do not respond to conventional therapies, but they should be used with caution.

Conclusion

Melasma is a challenging dermatological condition requiring a comprehensive approach for effective management. By combining sun protection, topical agents, oral medications, chemical peels, laser therapies, and lifestyle modifications, healthcare professionals can offer tailored treatment plans to their patients. Understanding the benefits and risks of each treatment modality is essential to optimize patient outcomes and minimize side effects. Regular follow-up and patient education are crucial for maintaining long-term results and preventing recurrence.